44000-P175131 World Bank <narrative>COVID-19 Response Project</narrative> International Bank for Reconstruction and DevelopmentMinistry of Finance and Economy of TurkmenistanInternational Bank for Reconstruction and Development International Development Association International Development AssociationMinistry of Health and Medical Industry of Turkmenistan Planned start date of the activity Actual start date of the activity Planned end date of the activity Actual end date of the activity The World Bank Oraz Sultanov +1-202-473-1000osultanov@worldbankgroup.org pic@worldbank.org The World Bank, 1818 H Street, NW, Washington, DC 20433 USA TURKMENISTAN Turkmenistan 39.75 59.66667 Ashgabat 37.95 58.38333 FY17 - Public Administration - HealthFY17 - HealthFY17 - Health Facilities and ConstructionPandemic ResponseHealth System StrengtheningHealth System StrengtheningICT SolutionsSocial InclusionICTHealth Service DeliveryDisease ControlHealth Systems and PoliciesHealth Systems and PoliciesParticipation and Civic EngagementAdaptationHealth FinanceHealth Service DeliveryHealth System StrengtheningICT 0.0000 0.0000 49800.0000 59740.0000 69500.0000 78640.0000 133060.0000 101220.0000 113920.0000 122140.0000 126180.0000 129500.0000 202180.0000 136720.0000 133840.0000 131680.0000 134560.0000 217920.0000 154000.0000 159360.0000 170320.0000 181840.0000 189540.0000 306740.0000 223080.0000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 49800.0000 59740.0000 69500.0000 78640.0000 133060.0000 101220.0000 113920.0000 122140.0000 126180.0000 129500.0000 202180.0000 136720.0000 133840.0000 131680.0000 134560.0000 217920.0000 154000.0000 159360.0000 170320.0000 181840.0000 189540.0000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20000000Total Commitment in June Month of 2021International Bank for Reconstruction and Development 50000Total Disbursement in September Month of 2021International Bank for Reconstruction and Development 14955481Total Disbursement in November Month of 2021International Bank for Reconstruction and Development 4994519Total Disbursement in December Month of 2022International Bank for Reconstruction and Development -50000Total Interest Repayment in September Month of 2021International Bank for Reconstruction and Development -61600Total Interest Repayment in April Month of 2022International Bank for Reconstruction and Development -205085Total Interest Repayment in October Month of 2022International Bank for Reconstruction and Development -461393Total Interest Repayment in April Month of 2023International Bank for Reconstruction and Development -607804Total Interest Repayment in October Month of 2023International Bank for Reconstruction and Development -657039Total Interest Repayment in April Month of 2024International Bank for Reconstruction and Development -652268Total Interest Repayment in October Month of 2024International Bank for Reconstruction and Development -558816Total Interest Repayment in April Month of 2025International Bank for Reconstruction and Development -550695Total Interest Repayment in October Month of 2025International Bank for Reconstruction and Development -489606Total Interest Repayment in April Month of 2026International Bank for Reconstruction and Development <narrative>Contract Awards</narrative><narrative>Project URL</narrative><narrative>Procurement Notices</narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 3: Number of designated beds for COVID-19 patients with access to continuous oxygen supply </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> List of equipment, consumables and medications for resuscitation and management of COVID-19 and SARI patients with lung function disorders is defined and regularly updated. </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 3: Number of designated beds for COVID-19 patients with access to continuous oxygen supply </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 2: Number of COVID-19 designated laboratories with verified diagnostic equipment and test kits. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Clinical protocols, including a referral system, to care for COVID-19 patients are regularly reviewed or updated </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of risk communication messages targeted to different population groups developed </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Percentage increase in risk awareness of COVID-19 among PHC nurses </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Electronic program for tracking and monitoring contacts developed and set up in Sanitary and Epidemiological Safety and Control (SESC) offices in Ashgabat and in five velayats </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of hospital and primary care physicians trained in the management of COVID-19 and SARI patients and adherence to COVID-19 protocols </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of health staff (physicians and nurses) trained in infection prevention and control in accordance with approved protocols </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of focus groups conducted to engage communities, understand their needs and receive feedback on the project </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of risk communication messages targeted to different population groups developed </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Hospital preparedness plans on COVID-19 are prepared in 5 infectious disease hospitals in 5 districts and health workers trained </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 3: Number of designated beds for COVID-19 patients with access to continuous oxygen supply </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of focus groups conducted to engage communities, understand their needs and receive feedback on the project </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 4: A National Pandemic Preparedness and Response Plan is regularly updated and tailored for each region. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> List of equipment, consumables and medications for resuscitation and management of COVID-19 and SARI patients with lung function disorders is defined and regularly updated. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> List of equipment, consumables and medications for resuscitation and management of COVID-19 and SARI patients with lung function disorders is defined and regularly updated. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of gender-specific information campaigns delivered. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of gender-specific information campaigns delivered. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of hospital and primary care physicians trained in the management of COVID-19 and SARI patients and adherence to COVID-19 protocols </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Percentage increase in risk awareness of COVID-19 among PHC nurses </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of risk communication messages targeted to different population groups developed </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of public health specialists trained on climate-induced vector borne diseases and waterborne diseases </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of health staff (physicians and nurses) trained in infection prevention and control in accordance with approved protocols </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 1: Development and periodic update of a comprehensive national COVID-19 risk communication plan, including standardized, evidence-based information targeted to different population group </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 4: A National Pandemic Preparedness and Response Plan is regularly updated and tailored for each region. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of hospital and primary care physicians trained in the management of COVID-19 and SARI patients and adherence to COVID-19 protocols </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Electronic program for tracking and monitoring contacts developed and set up in Sanitary and Epidemiological Safety and Control (SESC) offices in Ashgabat and in five velayats </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Hospital preparedness plans on COVID-19 are prepared in 5 infectious disease hospitals in 5 districts and health workers trained </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of focus groups conducted to engage communities, understand their needs and receive feedback on the project </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Clinical protocols, including a referral system, to care for COVID-19 patients are regularly reviewed or updated </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of COVID-19 designated laboratories with staff trained to conduct COVID-19 diagnosis </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 2: Number of COVID-19 designated laboratories with verified diagnostic equipment and test kits. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Percentage of participants in community meetings/events reporting that the local outreach and community engagement process is effective (disaggregated by gender) </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Percentage of participants in community meetings/events reporting that the local outreach and community engagement process is effective (disaggregated by gender) </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 1: Development and periodic update of a comprehensive national COVID-19 risk communication plan, including standardized, evidence-based information targeted to different population group </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Percentage of participants in community meetings/events reporting that the local outreach and community engagement process is effective (disaggregated by gender) </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 4: A National Pandemic Preparedness and Response Plan is regularly updated and tailored for each region. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of gender-specific information campaigns delivered. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of COVID-19 designated laboratories with staff trained to conduct COVID-19 diagnosis </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of COVID-19 designated laboratories with staff trained to conduct COVID-19 diagnosis </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 2: Number of COVID-19 designated laboratories with verified diagnostic equipment and test kits. </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of public health specialists trained on climate-induced vector borne diseases and waterborne diseases </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of public health specialists trained on climate-induced vector borne diseases and waterborne diseases </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Number of health staff (physicians and nurses) trained in infection prevention and control in accordance with approved protocols </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Hospital preparedness plans on COVID-19 are prepared in 5 infectious disease hospitals in 5 districts and health workers trained </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Electronic program for tracking and monitoring contacts developed and set up in Sanitary and Epidemiological Safety and Control (SESC) offices in Ashgabat and in five velayats </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Clinical protocols, including a referral system, to care for COVID-19 patients are regularly reviewed or updated </narrative> <narrative> rmediate Results Indicator </narrative> <narrative> Percentage increase in risk awareness of COVID-19 among PHC nurses </narrative> <narrative> Indicator </narrative> <narrative> PDO Indicator 1: Development and periodic update of a comprehensive national COVID-19 risk communication plan, including standardized, evidence-based information targeted to different population group </narrative>